MobiHealth News May 2, 2024
Jessica Hagen

The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.

Transcarent, a digital platform focused on the self-insured employer market, announced it secured a $126 million Series D investment. The funds bring the unicorn company’s total raise to $450 million and valuation to $2.2 billion.

General Catalyst and 7wireVentures led the round, with participation from new investors Memorial Hermann Health System and Geodesic Capital.

Former investors Human Capital, Kinnevik, Threshold Ventures, Ally Bridge Group, Alta Partners, Leaps by Bayer and Merck Global Health Innovation Fund also contributed to the Series D.

WHAT IT DOES

The California-based company focuses on self-insured employers and their employees. Members can virtually access care 24/7, and a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Investments, Technology, Trends
STAT+: NVIDIA’s Kimberly Powell touts progress on AI in drug discovery
Transcarent unveils new gen AI-enabled platform WayFinding
STAT+: Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis
Reddit soars after announcing OpenAI deal that allows use of its data for training AI models
Cutting Through the AI Hype: Deploying AI Now to Improve Patient Care

Share This Article